VVP
IONS icon

Venture Visionary Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Venture Visionary Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-63
Closed -$2.33K – 989
2022
Q2 		$2.33K Buy
+63
New +$2.38K ﹤0.01% 1521

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Venture Visionary Partners's IONS Position: Q3 2022 in Review

Venture Visionary Partners sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 63 shares — an estimated $2.33K sold.

Venture Visionary Partners first reported a position in IONS in Q2 2022 and held it in 1 quarter. The position peaked at $2.33K in Q2 2022. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • Venture Visionary Partners reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 63 Ionis Pharmaceuticals shares in Q3 2022, an estimated $2.33K.
  • Venture Visionary Partners first reported a position in Ionis Pharmaceuticals in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Ionis Pharmaceuticals position peaked at $2.33K in Q2 2022.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.